R

Respiri Ltd
ASX:RSH

Watchlist Manager
Respiri Ltd
ASX:RSH
Watchlist
Price: 0.078 AUD -3.7% Market Closed
Market Cap: 100.7m AUD
Have any thoughts about
Respiri Ltd?
Write Note

Respiri Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Respiri Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
IPD
C
CYC
COH
OIL
EMV

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
R
Respiri Ltd
ASX:RSH
Cash & Cash Equivalents
AU$762.9k
CAGR 3-Years
-54%
CAGR 5-Years
20%
CAGR 10-Years
-21%
ImpediMed Ltd
ASX:IPD
Cash & Cash Equivalents
AU$24.6m
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
9%
C
Cyclopharm Ltd
ASX:CYC
Cash & Cash Equivalents
AU$27.6m
CAGR 3-Years
-5%
CAGR 5-Years
37%
CAGR 10-Years
35%
Cochlear Ltd
ASX:COH
Cash & Cash Equivalents
AU$513.6m
CAGR 3-Years
-6%
CAGR 5-Years
46%
CAGR 10-Years
25%
Optiscan Imaging Ltd
ASX:OIL
Cash & Cash Equivalents
AU$6.1m
CAGR 3-Years
-10%
CAGR 5-Years
28%
CAGR 10-Years
56%
EMvision Medical Devices Ltd
ASX:EMV
Cash & Cash Equivalents
AU$18.6m
CAGR 3-Years
24%
CAGR 5-Years
34%
CAGR 10-Years
N/A

See Also

What is Respiri Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
762.9k AUD

Based on the financial report for Jun 30, 2024, Respiri Ltd's Cash & Cash Equivalents amounts to 762.9k AUD.

What is Respiri Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-21%

Over the last year, the Cash & Cash Equivalents growth was 422%. The average annual Cash & Cash Equivalents growth rates for Respiri Ltd have been -54% over the past three years , 20% over the past five years , and -21% over the past ten years .

Back to Top